Literature DB >> 1488888

The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey.

M Soylu1, T R Ersöz, E Erken.   

Abstract

HLA B5 plays an important role in the aetiology of Behçet's disease. The frequency of HLA B5 differs between racial groups and geographical regions. Ocular involvement, which could lead to serious complications, is a very important feature of Behçet's disease. Various racial groups having different genetic properties live in the Cukurova region, located in southern Turkey. To investigate the role of HLA B5 in Behçet's disease in Cukurova region, HLA B5 antigens were investigated by lymphocytotoxicity assay in 65 patients and 200 healthy controls. A significantly higher frequency was found in the patient group. Neither ocular involvement, nor the type of uveitis showed any correlation with HLA B5, but it was found that patients presenting with frequent ocular attacks had significantly higher HLA B5 positivity than the patients with rare attacks. This observation suggests that HLA B5 would be a negative factor in visual prognosis in Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488888     DOI: 10.1111/j.1755-3768.1992.tb04888.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  8 in total

1.  Primary association of HLA-B51 with Behçet's disease in Ireland.

Authors:  D J Kilmartin; A Finch; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

Review 2.  Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Bruno Frediani; Rossella Franceschini; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Claudia Fabiani; Luca Cantarini
Journal:  Rheumatol Int       Date:  2017-07-27       Impact factor: 2.631

3.  Neurological manifestations of Behçet's disease in Japan: a study of 54 patients.

Authors:  Haruko Ideguchi; Akiko Suda; Mitsuhiro Takeno; Yohei Kirino; Atsushi Ihata; Atsuhisa Ueda; Shigeru Ohno; Yasuhisa Baba; Yoshiyuki Kuroiwa; Yoshiaki Ishigatsubo
Journal:  J Neurol       Date:  2010-02-03       Impact factor: 4.849

4.  Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

Authors:  I Kötter; A K Eckstein; N Stübiger; M Zierhut
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

Review 5.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

Review 6.  Syndromes of hearing loss associated with visual loss.

Authors:  Kamal Ahmed Abou-Elhamd; Hesham Mohamed ElToukhy; Fahad Abdullah Al-Wadaani
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-30       Impact factor: 2.503

7.  Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.

Authors:  Jurgen Sota; Luca Cantarini; Antonio Vitale; Arianna Sgheri; Stefano Gentileschi; Valeria Caggiano; Viviana Gelardi; Bruno Frediani; Gian Marco Tosi; Claudia Fabiani
Journal:  Mediators Inflamm       Date:  2020-05-15       Impact factor: 4.711

8.  Succinivibrionaceae is dominant family in fecal microbiota of Behçet's Syndrome patients with uveitis.

Authors:  Duygu Tecer; Feride Gogus; Ayse Kalkanci; Merve Erdogan; Murat Hasanreisoglu; Çagri Ergin; Tarkan Karakan; Ramazan Kozan; Seda Coban; Kadir Serdar Diker
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.